2022
2021
2020
2019
2018
2017
2016
2015
2014
Tenax Therapeutics Provides Regulatory Update on Levosimendan
Jul 28, 2017
Tenax Meets with FDA to Discuss Positive Mortality Data and Potential Levosimendan NDA Submission
May 16, 2017
Tenax Therapeutics Announces Review of Strategic Alternatives and Business Update
Apr 5, 2017
Tenax Therapeutics Announces Year-End 2016 Financial Results and Provides Corporate Update
Mar 21, 2017
Tenax Therapeutics to Discuss Year-End 2016 Financial Results and Provide Business Update
Mar 15, 2017
Tenax Therapeutics Announces Top-Line Results From Phase 3 LEVO-CTS Trial in Cardiac Surgery
Jan 31, 2017